Alnylam Pharmaceuticals : ALNY

All Alnylam Pharmaceuticals Articles

78 Articles

Paul Ausick | Oct 6, 2016 at 4:04 PM EDT

Alnylam, Mylan Tumble into Thursday’s 52-Week Low Club

October 6, 2016: Here are four stocks trading with relatively heavy volume among 34 equities making new 52-week lows in…

Chris Lange | Oct 6, 2016 at 11:35 AM EDT

Alnylam Pharma Crashes on Discontinued Late-Stage Trial

Alnylam Pharmaceuticals saw its shares crash on Thursday after the company announced that it will be discontinuing one of its…

Jon C. Ogg | Oct 6, 2016 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: American Express, Encana, Petrobras, Raytheon, Tesla, Walgreens and More

The top analyst upgrades, downgrades and initiations seen on Thursday morning include American Express, Encana, Petrobras, Raytheon, Tesla and Walgreens.

Jon C. Ogg | Sep 29, 2016 at 9:05 AM EDT

Top Analyst Upgrades and Downgrades: Apple, BlackBerry, eBay, Fitbit, Lululemon, Nike and More

The top analyst upgrades, downgrades and initiations seen on Thursday morning include Apple, BlackBerry, eBay, Fitbit, Lululemon Athletica and Nike.

Jon C. Ogg | Mar 11, 2016 at 8:55 AM EST

Top Analyst Upgrades and Downgrades: Blackstone, Chevron, Diamond Offshore, Palo Alto, Symantec, Total and More

The top analyst upgrades, downgrades and initiations seen from Friday, March 11, include Blackstone, Chevron, Diamond Offshore Drilling, Palo Alto…

Jon C. Ogg | Jan 20, 2016 at 8:55 AM EST

Top Analyst Upgrades and Downgrades: AMD, Amazon, Celgene, Comerica, Fortinet, Gilead, Lennar, Netflix, Voya, Wayfair and Many More

Wednesday's top analyst calls include AMD, Amazon.com, Celgene, Comerica, Fortinet, Gilead Sciences, Lennar, Netflix, Voya and Wayfair.

Chris Lange | Aug 31, 2015 at 9:15 AM EDT

The Medicines Company and Alnylam Rise on Positive Phase 1 Results

Alnylam Pharmaceuticals and The Medicines Company made waves Monday morning despite downward pressure from the broad markets.

Jon C. Ogg | May 8, 2015 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Alcatel-Lucent, Alibaba, CyberArk, Yelp, Rocket Fuel, Choice Hotels and More

Friday's top analyst upgrades, downgrades and initiations include Alcatel-Lucent, Alibaba, CyberArk, Yelp, Rocket Fuel and Choice Hotels.

Jon C. Ogg | Mar 4, 2015 at 8:55 AM EST

Top Analyst Upgrades and Downgrades: Alcoa, Apache, Bob Evans, F5 Networks, McDonald’s and More

Wednesday's top analyst upgrades, downgrades and initiations includes Alcoa, Apache, Bob Evans, F5, Hain and McDonald's.

Lee Jackson | Jan 31, 2015 at 9:10 AM EST

Volatile Market Week Doesn’t Stop Insiders From Buying Stock

With volatility spiking much higher than last year, one thing that bodes well for equity investors is the number of…

Jon C. Ogg | Jan 8, 2015 at 8:40 AM EST

Top Analyst Upgrades and Downgrades: Alcatel-Lucent, ADM, BofA, Chesapeake, Google, J.P. Morgan, MGM and More

Thursday's top analyst upgrades, downgrades and initiations seen from Wall Street research calls includes Alcatel-Lucent, ADM, Bank of America, Chesapeake…

Jon C. Ogg | Dec 12, 2014 at 8:25 AM EST

Top Analyst Upgrades and Downgrades: Citrix, GoPro, HP, Microsoft, Oracle, Teva and More

Friday's top analyst upgrades, downgrades and initiations include Citrix Systems, GoPro, Hewlett-Packard, Microsoft, Oracle and Teva Pharmaceutical.

Lee Jackson | Sep 25, 2014 at 8:35 AM EDT

5 Orphan Drug Biotech Stocks to Buy With Big Upside Potential

For many of the top biotech companies, orphan drugs have morphed into huge winners and have even generated other streams…

Lee Jackson | Aug 11, 2014 at 9:34 AM EDT

New Analyst Biotech Stocks to Buy With Gigantic Implied Upside

ThinkstockAfter being absolutely rocked back in the spring, the biotech sector has bounced back smartly. Even a bubble comment from…

Jon C. Ogg | Jun 11, 2013 at 8:00 AM EDT

Top 10 Analyst Upgrades and Downgrades: Lululemon, Apple, Disney and More

These are the top analyst upgrades, downgrades and initiations from select Wall Street research calls on Tuesday, June 11, 2013.…

1 2 3 4 5 6

Alnylam Pharmaceuticals : ALNY

All Alnylam Pharmaceuticals Articles

Alnylam, Mylan Tumble into Thursday’s 52-Week Low Club

Alnylam Pharma Crashes on Discontinued Late-Stage Trial

Top Analyst Upgrades and Downgrades: American Express, Encana, Petrobras, Raytheon, Tesla, Walgreens and More

Top Analyst Upgrades and Downgrades: Apple, BlackBerry, eBay, Fitbit, Lululemon, Nike and More

Top Analyst Upgrades and Downgrades: Blackstone, Chevron, Diamond Offshore, Palo Alto, Symantec, Total and More

Top Analyst Upgrades and Downgrades: AMD, Amazon, Celgene, Comerica, Fortinet, Gilead, Lennar, Netflix, Voya, Wayfair and Many More

The Medicines Company and Alnylam Rise on Positive Phase 1 Results

Top Analyst Upgrades and Downgrades: Alcatel-Lucent, Alibaba, CyberArk, Yelp, Rocket Fuel, Choice Hotels and More

Top Analyst Upgrades and Downgrades: Alcoa, Apache, Bob Evans, F5 Networks, McDonald’s and More

Volatile Market Week Doesn’t Stop Insiders From Buying Stock

Top Analyst Upgrades and Downgrades: Alcatel-Lucent, ADM, BofA, Chesapeake, Google, J.P. Morgan, MGM and More

Top Analyst Upgrades and Downgrades: Citrix, GoPro, HP, Microsoft, Oracle, Teva and More

5 Orphan Drug Biotech Stocks to Buy With Big Upside Potential

New Analyst Biotech Stocks to Buy With Gigantic Implied Upside

Top 10 Analyst Upgrades and Downgrades: Lululemon, Apple, Disney and More

Goldman Sachs Just Made 4 Bold Calls: 2 Sells, 1 Buy, and a $2,159 Price Target On This Popular Stock

Palantir CEO: “Something Has Gone Completely Wrong” With OpenAI and Anthropic

Pay for Daycare With Pre-Tax Dollars. Most Parents Leave Thousands on the Table Every Year

Pay for Daycare With Pre-Tax Dollars. Most Parents Leave Thousands on the Table Every Year

The Aircraft Loophole That Lets Any Business Erase Millions in One Tax Year

Goldman Sachs Just Made 4 Bold Calls: 2 Sells, 1 Buy, and a $2,159 Price Target On This Popular Stock

Palantir CEO: “Something Has Gone Completely Wrong” With OpenAI and Anthropic

Alnylam Pharmaceuticals : ALNY

All Alnylam Pharmaceuticals Articles

Alnylam, Mylan Tumble into Thursday’s 52-Week Low Club

Alnylam Pharma Crashes on Discontinued Late-Stage Trial

Top Analyst Upgrades and Downgrades: American Express, Encana, Petrobras, Raytheon, Tesla, Walgreens and More

Top Analyst Upgrades and Downgrades: Apple, BlackBerry, eBay, Fitbit, Lululemon, Nike and More

Top Analyst Upgrades and Downgrades: Blackstone, Chevron, Diamond Offshore, Palo Alto, Symantec, Total and More

Top Analyst Upgrades and Downgrades: AMD, Amazon, Celgene, Comerica, Fortinet, Gilead, Lennar, Netflix, Voya, Wayfair and Many More

The Medicines Company and Alnylam Rise on Positive Phase 1 Results

Top Analyst Upgrades and Downgrades: Alcatel-Lucent, Alibaba, CyberArk, Yelp, Rocket Fuel, Choice Hotels and More

Top Analyst Upgrades and Downgrades: Alcoa, Apache, Bob Evans, F5 Networks, McDonald’s and More

Volatile Market Week Doesn’t Stop Insiders From Buying Stock

Top Analyst Upgrades and Downgrades: Alcatel-Lucent, ADM, BofA, Chesapeake, Google, J.P. Morgan, MGM and More

Top Analyst Upgrades and Downgrades: Citrix, GoPro, HP, Microsoft, Oracle, Teva and More

5 Orphan Drug Biotech Stocks to Buy With Big Upside Potential

New Analyst Biotech Stocks to Buy With Gigantic Implied Upside

Top 10 Analyst Upgrades and Downgrades: Lululemon, Apple, Disney and More

Goldman Sachs Just Made 4 Bold Calls: 2 Sells, 1 Buy, and a $2,159 Price Target On This Popular Stock

Palantir CEO: “Something Has Gone Completely Wrong” With OpenAI and Anthropic

Pay for Daycare With Pre-Tax Dollars. Most Parents Leave Thousands on the Table Every Year

Featured Reads

Pay for Daycare With Pre-Tax Dollars. Most Parents Leave Thousands on the Table Every Year

The Aircraft Loophole That Lets Any Business Erase Millions in One Tax Year